<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药明康德 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-21T11:38:14+08:00</updated>
  <subtitle>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>辉瑞/BioNTech递交新冠疫苗EUA申请，然后呢？</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/hTKYVVSPehlO4XWgPnUEww</id>
    <link href="https://mp.weixin.qq.com/s/hTKYVVSPehlO4XWgPnUEww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 获优先审评资格，首款靶向CD19的ADC有望问世</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/SmRFcZAWk9sYgdOZ9kbfeg</id>
    <link href="https://mp.weixin.qq.com/s/SmRFcZAWk9sYgdOZ9kbfeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA今日批准首个早衰症疗法</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/gBcaddvEH0By3NHGPalkvQ</id>
    <link href="https://mp.weixin.qq.com/s/gBcaddvEH0By3NHGPalkvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罕见病专栏 | 一周罕闻药事（11.14-11.20）</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/R0j6giPzetdzJNeG-Xqk8A</id>
    <link href="https://mp.weixin.qq.com/s/R0j6giPzetdzJNeG-Xqk8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《细胞》：传播性变强之外，新冠D614G突变毒株的致病性有什么变化</title>
    <updated>2020-11-21T08:10:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/hnKb4Nc_xRe_BBoM0ADDjg</id>
    <link href="https://mp.weixin.qq.com/s/hnKb4Nc_xRe_BBoM0ADDjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康疫苗可保护老年群体；十年老药有望治疗重症新冠患者</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/2eneeRlLFugglIiWuO4u1A</id>
    <link href="https://mp.weixin.qq.com/s/2eneeRlLFugglIiWuO4u1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 第三款RNAi药物今日获欧盟批准</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/zlPi9-RNC3WhU-GN5KlBsA</id>
    <link href="https://mp.weixin.qq.com/s/zlPi9-RNC3WhU-GN5KlBsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>跳过体外环节，在患者体内直接改造T细胞，细胞疗法新锐公司完成A轮融资！</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/3yiXS19tAYj1H704JymLSA</id>
    <link href="https://mp.weixin.qq.com/s/3yiXS19tAYj1H704JymLSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM：优于NSCLC一线标准治疗，三代ALK抑制剂降低疾病进展或死亡风险72%</title>
    <updated>2020-11-20T07:53:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/SShAVdeka-SwS6ZEDuuc7A</id>
    <link href="https://mp.weixin.qq.com/s/SShAVdeka-SwS6ZEDuuc7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明生基扩建美国费城细胞及基因疗法生产基地， 提升高端测试服务规模 | Bilingual News</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/5KljX6kuCOkdpK27VrjPtA</id>
    <link href="https://mp.weixin.qq.com/s/5KljX6kuCOkdpK27VrjPtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>保护效力达95%，辉瑞/BioNTech即将向FDA递交新冠疫苗EUA申请</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/HGs0UCj5EM2qOGcnPROllg</id>
    <link href="https://mp.weixin.qq.com/s/HGs0UCj5EM2qOGcnPROllg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 腾盛博药与VBI Vaccines公司宣布慢性乙型肝炎免疫疗法在1b/2a试验中期获得积极数据</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/EwkA0FBUZP98J50ZM1w-KQ</id>
    <link href="https://mp.weixin.qq.com/s/EwkA0FBUZP98J50ZM1w-KQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 赛诺菲庞贝病疗法获FDA优先审评资格，有望成为新标准疗法</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/EwaDlOmC943mk-W0CKWzgA</id>
    <link href="https://mp.weixin.qq.com/s/EwaDlOmC943mk-W0CKWzgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首款可全部在家中完成的新冠核酸检测获FDA紧急使用授权</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/DjkVvtTmX55jIf2078RHxA</id>
    <link href="https://mp.weixin.qq.com/s/DjkVvtTmX55jIf2078RHxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>治疗阿尔茨海默病，要多早开始？科学家重新定义“早期”，治疗事半功倍</title>
    <updated>2020-11-19T07:40:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/9MiHmWWNNNrEKo_a6iuoiQ</id>
    <link href="https://mp.weixin.qq.com/s/9MiHmWWNNNrEKo_a6iuoiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>权威榜单：2020年值得关注的10家初创公司来了！</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/pSJh8si_r1v6e7CiKYuZsQ</id>
    <link href="https://mp.weixin.qq.com/s/pSJh8si_r1v6e7CiKYuZsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿诺医药CEO路杨先生：创新和差异化并举，将癌症变成一种非致命疾病！</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/6XfO_QUg4C2DmJifWogjWg</id>
    <link href="https://mp.weixin.qq.com/s/6XfO_QUg4C2DmJifWogjWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 长效HIV预防新药获FDA突破性疗法认定，优于标准疗法66%</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/2TFlAGuDbRb4JNitlo4ozw</id>
    <link href="https://mp.weixin.qq.com/s/2TFlAGuDbRb4JNitlo4ozw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 2.6亿欧元开发免疫疾病创新疗法，罗氏达成研发合作</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/hpxTuW6XWr51Eweqv6owOw</id>
    <link href="https://mp.weixin.qq.com/s/hpxTuW6XWr51Eweqv6owOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA局长发表声明，致力维护COVID-19紧急使用授权（EUA）的透明度</title>
    <updated>2020-11-18T08:13:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/HyckOgOyLurP-5NMQiostg</id>
    <link href="https://mp.weixin.qq.com/s/HyckOgOyLurP-5NMQiostg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>